BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 86499)

  • 1. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
    Fike RM; van Oss CJ
    Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
    Harlos JP; Weiss L
    Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
    Glaves D; Harlos JP; Weiss L
    Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
    Crozier EH; Hollinger ME; Woodend BE; Robertson JH
    J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
    Jenssen R; Jenssen HL; Köhler H; Friemel H
    Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
    Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
    Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on lymphokine activity in concanavalin A-stimulated lymphocyte supernatants using the macrophage-electrophoretic-mobility-test (MEM-test).
    Kotzsch M; Grossmann H; Irmscher J; Müller M
    Exp Pathol; 1982; 21(3):143-8. PubMed ID: 7117487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests.
    Shenton BK; Jenssen HL; Werner H; Field EJ
    J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity.
    Malkovský M; Bubeník J; Holán V; Hasek M
    Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of binding of human lymphocyte products to guinea pig macrophages.
    Weiss L; Harlos JP; Subjeck JR
    Cell Biophys; 1979 Mar; 1(1):65-77. PubMed ID: 95169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
    Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
    Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
    Günther J
    Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
    Balakrishnan K; Hanjan SN; Talwar JP
    Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
    Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
    Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macrophage electrophoretic mobility test (MEM) some technical considerations.
    Shenton BK; Field EJ
    J Immunol Methods; 1975 Jun; 7(2-3):149-62. PubMed ID: 1095654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.